Syngen Biotech Co.,Ltd. (8279.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$79.00 (-0.38%) as of
Key statistics
- Market cap
- 2.14B
- P/E (TTM)
- 9.53
- EPS (TTM)
- 8.29
- Dividend yield
- 6.31%
- 52-week range
- 77.60 – 141.00
- Beta
- 0.13
- Revenue (TTM)
- 2.05B
- Profit margin
- 11.01%
- Volume
- 7.01k
About Syngen Biotech Co.,Ltd.
Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, and capsules; and elderly health care, beauty enhancing supplements, probiotics, digestive aids and enzymes, weight loss and nutrition, immune acid, fitness and energy, and pet supplement products. It also provides science-based and bio active pharmaceutical ingredients, including Oraltics, a lactobacillus fermentum SG-A95; IMMUPHYLA, a heat-killed lactobacillus paracasei LCW23; V3, a lactobacillus fermentum; ST4SanTex, a streptococcus thermophilus; GUARDSPO, a bacillus coagulans; benefiGANO, a ganoderma lucidum, EXPUNERGY, a hirsutella sinensis mycelium; and BIOJOVIAL, a lactobacillus brevis. In addition, the company offers organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. It serves sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. Syngen Biotech Co.,Ltd. was founded in 1988 and is based in Tainan City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Tainan City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.